SOMERSET THERAPEUTICS LLC recalls
4 recalls.
- Dexamethasone Sodium Phosphate Injection recall (SOMERSET THERAPEUTICS LLC)
DrugClass IIReported March 25, 2026 · Failed Impurities/Degradation Specifications - OOS impurities result observed during long term stability testing at product expiry (24 months) were above specs... - Cisatracurium Besylate Injection USP recall (SOMERSET THERAPEUTICS LLC)
DrugClass IIIReported December 24, 2025 · Subpotent product:out of specification assay results observed during long term stability testing. - Cisatracurium Besylate Injection USP recall (SOMERSET THERAPEUTICS LLC)
DrugClass IIIReported December 24, 2025 · Subpotent product:out of specification assay results observed during long term stability testing. - Cisatracurium Besylate Injection USP recall (SOMERSET THERAPEUTICS LLC)
DrugClass IIIReported December 24, 2025 · Subpotent product:out of specification assay results observed during long term stability testing.